Tapotoclax (AMG-176) is a potent, selective and orally active MCL-1 inhibitor, with a K i of 0.13 nM.
Storage Temp
Store at -20°C
Shipped In
Ice chest + Ice pads
Product Description
Tapotoclax (AMG-176) is a potent, selective and orally active MCL-1 inhibitor, with a K i of 0.13 nM
In Vitro
Tapotoclax is an inhibitor of induced myeloid leukemia cell differentiation protein MCL-1 (K i =0.13 nM), with potential pro-apoptotic and antineoplastic activities. Upon administration, Tapotoclax binds to and inhibits the activity of MCL-1. This disrupts the formation of MCL-1/Bcl-2-like protein 11 (BCL2L11; BIM) complexes and induces apoptosis in tumor cells . MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Form:Solid
IC50& Target:Mcl-1 0.13 nM (Ki)
Associated Targets(Human)
MCL1TchemInduced myeloid leukemia cell differentiation protein Mcl-1 (3 Activities)